Vascular Response After Everolimus-Eluting Stent in Acute Myocardial Infarction Caused by Calcified Nodule

Yasushi Ino1, Masahiro Takahata1, Takashi Kubo1

  • 1Department of Cardiovascular Medicine, Wakayama Medical University.

Insights

Patients with acute myocardial infarction (AMI) due to calcified nodules (CN) experience poorer outcomes after percutaneous coronary intervention (PCI). Late stent healing is worse in CN patients compared to plaque rupture or erosion, indicating a need for further research.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomedical Imaging

Background:

  • Acute myocardial infarction (AMI) patients with calcified nodules (CN) exhibit worse clinical outcomes post-primary percutaneous coronary intervention (PCI).
  • Understanding the late vascular response in these patients is crucial for improving treatment strategies.

Purpose of the Study:

  • To investigate the late vascular response after everolimus-eluting stent (EES) implantation in patients with AMI caused by CN.
  • To compare this response with that in patients experiencing plaque rupture (PR) or plaque erosion (PE) using optical coherence tomography (OCT).

Main Methods:

  • 141 AMI patients were categorized into PR (60%), PE (32%), or CN (8%) groups based on pre-PCI OCT findings.
  • OCT imaging was performed immediately and 10 months post-PCI to assess stent healing and complications.
  • Vascular response metrics included uncovered and malapposed struts, intra-stent thrombus, CN re-appearance, and target lesion revascularization.

Main Results:

  • The CN group showed significantly higher frequencies of uncovered (82%) and malapposed struts (73%) at 10-month follow-up compared to PR and PE groups.
  • Incidence of intra-stent thrombus (36%), CN re-appearance within the stent (27%), and target lesion revascularization (18%) were markedly higher in the CN group.
  • These findings indicate a poorer late arterial healing response in patients with CN-related AMI.

Conclusions:

  • Late arterial healing after EES implantation is significantly worse in patients with AMI caused by calcified nodules compared to plaque rupture or plaque erosion.
  • These findings highlight the challenges associated with treating AMI in the presence of calcified nodules and underscore the need for tailored therapeutic approaches.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
28
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
92
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
58